Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Nov-22 4:19 PM View:  | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Nov-22 | Option Exercise | 100,000 | $1.42 | $142,000.00 | 43% 230.06K to 330.06K | |
| 16-Nov-22 4:19 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Nov-22 | Option Sale | 31,515 | $13.88 | $437,428.00 | (10%) 330.06K to 298.54K | |
| 09-Mar-22 4:24 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Mar-22 | Private Sale | 20,000 | $17.16 | $343,200.00 | (8%) 250.06K to 230.06K | |
| 16-Dec-21 5:09 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-21 | Grant | 35,000 | -- | -- | 16% 215.06K to 250.06K | |
| 09-Dec-21 4:38 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Dec-21 | Option Exercise | 62,000 | $4.73 | $293,260.00 | 34% 183.16K to 245.16K | |
| 09-Dec-21 4:38 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Dec-21 | Market Option Sale | 30,100 | $12.20 | $367,220.00 | (12%) 245.16K to 215.06K | |
| 23-Feb-21 4:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Feb-21 | Payment of Exercise | 22,431 | $11.53 | $258,629.00 | (11%) 205.59K to 183.16K | |
| 23-Feb-21 4:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Feb-21 | Option Exercise | 50,000 | $4.15 | $207,500.00 | 32% 155.59K to 205.59K | |
| 18-Nov-19 4:03 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Nov-19 | Private Purchase | 25,000 | $1.45 | $36,250.00 | 19% 130.59K to 155.59K | |
| 04-Feb-19 4:13 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Jan-19 | Payment of Exercise | 9,387 | $8.68 | $81,479.20 | (7%) 139.97K to 130.59K | 13% |
| 04-Feb-19 4:13 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Jan-19 | Option Exercise | 31,874 | $1.20 | $38,248.80 | 29% 108.1K to 139.97K | |
| 03-Jan-19 4:36 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-19 | Payment of Exercise | 771 | $8.07 | $6,221.97 | (< 1%) 108.87K to 108.1K | 7% |
| 08-Mar-18 3:48 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 06-Mar-18 | Payment of Exercise | 21,125 | $5.18 | $109,428.00 | (16%) 130.0K to 108.87K | (45%) |
| 08-Mar-18 3:48 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 06-Mar-18 | Option Exercise | 30,000 | $3.26 | $97,800.00 | 30% 100.0K to 130.0K | |
| 23-Jan-18 9:10 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-18 | Payment of Exercise | 3,872 | $5.59 | $21,644.50 | (4%) 103.87K to 100.0K | (35%) |
| 03-Jan-18 9:11 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-18 | Payment of Exercise | 838 | $4.91 | $4,114.58 | (< 1%) 104.71K to 103.87K | (53%) |
| 24-Jan-17 9:25 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-17 | Payment of Exercise | 5,083 | $5.95 | $30,243.80 | (5%) 109.79K to 104.71K | (27%) |
| 03-Jan-17 2:09 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-17 | Payment of Exercise | 1,639 | $6.33 | $10,374.90 | (1%) 111.43K to 109.79K | (19%) |
| 29-Aug-16 10:46 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 25-Aug-16 | Market Sale | 30,000 | $4.06 | $121,800.00 | (21%) 141.43K to 111.43K | (86%) |
| 03-Mar-16 9:47 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-16 | Payment of Exercise | 906 | $2.13 | $1,929.78 | (< 1%) 142.33K to 141.43K | (253%) |
| 22-Jan-16 9:24 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-16 | Payment of Exercise | 4,724 | $7.55 | $35,666.20 | (3%) 147.06K to 142.33K | < 1% |
| 05-Jan-16 1:29 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-16 | Payment of Exercise | 1,639 | $10.32 | $16,914.50 | (1%) 148.7K to 147.06K | 27% |
| 20-Mar-15 4:30 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Mar-15 | Market Sale | 12,105 | $10.16 | $122,987.00 | (8%) 160.8K to 148.7K | 26% |
| 06-Mar-15 2:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 05-Mar-15 | Market Sale | 37,400 | $10.59 | $396,066.00 | (19%) 198.2K to 160.8K | 29% |
| 05-Mar-15 2:58 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-15 | Market Sale | 10,495 | $10.50 | $110,198.00 | (5%) 208.7K to 198.2K | 28% |
| 03-Mar-15 3:56 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-15 | Payment of Exercise | 1,634 | $10.20 | $16,666.80 | (< 1%) 210.33K to 208.7K | 26% |
| 22-Jan-15 12:16 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-15 | Payment of Exercise | 4,362 | $11.17 | $48,723.50 | (2%) 214.69K to 210.33K | 33% |
| 05-Jan-15 4:10 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-15 | Grant | 8,900 | -- | -- | 4% 208.19K to 217.09K | |
| 05-Jan-15 4:10 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-15 | Payment of Exercise | 2,402 | $12.16 | $29,208.30 | (1%) 217.09K to 214.69K | 38% |
| 07-Mar-14 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Option Exercise | 28,816 | $8.37 | $241,177.00 | 13% 220.02K to 248.84K | |
| 07-Mar-14 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Market Option Sale | 28,816 | $12.57 | $362,217.00 | (12%) 248.84K to 220.02K | 40% |
| 07-Mar-14 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 04-Mar-14 | Market Sale | 11,826 | $12.57 | $148,653.00 | (5%) 220.02K to 208.19K | 40% |
| 07-Mar-14 4:14 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-14 | Payment of Exercise | 1,618 | $11.69 | $18,914.40 | (< 1%) 221.64K to 220.02K | 36% |
| 25-Feb-14 2:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-Feb-14 | Payment of Exercise | 8,170 | $12.20 | $99,674.00 | (4%) 229.81K to 221.64K | 38% |
| 25-Feb-14 2:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 24-Feb-14 | Option Exercise | 23,179 | $4.30 | $99,669.70 | 11% 206.63K to 229.81K | |
| 04-Feb-14 3:50 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-14 | Grant | 54,000 | -- | -- | 35% 152.63K to 206.63K | |
| 03-Jan-14 3:51 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-14 | Payment of Exercise | 2,402 | $7.60 | $18,255.20 | (2%) 155.03K to 152.63K | < 1% |
| 06-Mar-13 4:42 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-13 | Payment of Exercise | 1,903 | $1.19 | $2,264.57 | (1%) 156.94K to 155.03K | (534%) |
| 07-Jan-13 3:05 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-13 | Grant | 17,000 | -- | -- | 12% 139.94K to 156.94K | |
| 19-Mar-12 12:19 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Mar-12 | Grant | 21,038 | -- | -- | 17% 125.77K to 146.81K | |
| 19-Mar-12 12:19 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Mar-12 | Payment of Exercise | 6,872 | $5.23 | $35,940.60 | (5%) 146.81K to 139.94K | (44%) |
| 05-Mar-12 2:30 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 02-Mar-12 | Market Sale | 837 | $4.78 | $4,000.86 | (< 1%) 126.61K to 125.77K | (58%) |
| 05-Mar-12 2:30 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-12 | Grant | 11,200 | -- | -- | 10% 115.41K to 126.61K | |
| 01-Mar-12 2:59 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Feb-12 | Option Exercise | 53,668 | -- | -- | 102% 52.74K to 106.41K | |
| 23-Feb-12 4:40 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 22-Feb-12 | Option Exercise | 30,912 | $1.19 | $36,780.90 | 59% 52.74K to 83.65K | |
| 23-Feb-12 4:40 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 22-Feb-12 | Market Option Sale | 30,912 | $4.22 | $130,449.00 | (37%) 83.65K to 52.74K | (79%) |
| 03-Mar-11 2:52 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-11 | Grant | 9,000 | -- | -- | 17% 52.74K to 61.74K | |
| 05-Jan-10 9:51 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Dec-09 | Payment of Exercise | 6,137 | $6.46 | $39,645.00 | (10%) 58.88K to 52.74K | (15%) |
| 28-Oct-09 10:14 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 26-Oct-09 | Market Sale (Planned) | 6,400 | $10.85 | $69,422.10 | (14%) 45.76K to 39.36K | 31% |
| 22-Oct-09 1:29 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 21-Oct-09 | Market Sale (Planned) | 200 | $10.00 | $2,000.00 | (< 1%) 45.96K to 45.76K | 26% |